Name | 4-({Benzyl[(8-chloro-1-methyl-1,4-dihydrochromeno[4,3-c]pyrazol-3-yl)carbonyl]amino}methyl)benzoic acid |
---|---|
Synonyms |
Benzoic acid, 4-[[[(8-chloro-1,4-dihydro-1-methyl[1]benzopyrano[4,3-c]pyrazol-3-yl)carbonyl](phenylmethyl)amino]methyl]-
4-({Benzyl[(8-chloro-1-methyl-1,4-dihydrochromeno[4,3-c]pyrazol-3-yl)carbonyl]amino}methyl)benzoic acid |
Description | Nidufexor is a farnesoid X receptor (FXR) agonist[1]. |
---|---|
Related Catalog | |
Target |
FXR[1] |
References |
[1]. Proposed INN: List 118. WHO Drug Information, Vol. 31, No. 4, 2017. |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 781.1±60.0 °C at 760 mmHg |
Molecular Formula | C27H22ClN3O4 |
Molecular Weight | 487.93 |
Flash Point | 426.2±32.9 °C |
Exact Mass | 487.129883 |
LogP | 3.72 |
Vapour Pressure | 0.0±2.8 mmHg at 25°C |
Index of Refraction | 1.671 |
Storage condition | 2-8℃ |